Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Apr 2, 2016Virtual Press Office and PR Newswire: General Trade show news
Findings from a clinical trial comparing Victoza® (liraglutide [rDNA origin] injection) and sitagliptin (100 mg), both in combination with metformin, demonstrated that switching from sitagliptin...
-
Apr 2, 2016Virtual Press Office and PR Newswire: General Trade show news
Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced findings from two new studies demonstrating the clinical utility of the Afirma...
-
Apr 2, 2016Virtual Press Office and PR Newswire: General Trade show news
Findings from the first phase 3a clinical trial for semaglutide, an investigational glucagon-like peptide-1 (GLP-1) analogue, demonstrated that treatment with semaglutide, administered once...
-
Apr 2, 2016Virtual Press Office and PR Newswire: General Trade show news
Boehringer Ingelheim Pharmaceuticals, Inc. today announced the results of a new interim analysis of data from the ongoing phase III RE-VERSE AD™ patient study that showed a single 5g dose of...
-
Apr 2, 2016Virtual Press Office and PR Newswire: General Trade show news
Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that the randomized PARTNER...